The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes.

Mutations in CARD14 have recently been linked to psoriasis susceptibility. CARD14 is an epidermal regulator of NF-κB activation. However, the ability of CARD14 to activate other signaling pathways as well as the biochemical mechanisms that mediate and regulate its function remain to be determined. Here, we report that in addition ...
to NF-κB signaling, CARD14 activates p38 and JNK MAP kinase pathways, all of which are dependent on the paracaspase MALT1. Mechanistically, we demonstrate that CARD14 physically interacts with paracaspase MALT1 and activates MALT1 proteolytic activity and inflammatory gene expression, which are enhanced by psoriasis-associated CARD14 mutations. Moreover, we show that MALT1 deficiency or pharmacological inhibition of MALT1 catalytic activity inhibits pathogenic mutant CARD14-induced cytokine and chemokine expression in human primary keratinocytes. Collectively, our findings demonstrate a novel role for MALT1 in CARD14-induced signaling and indicate MALT1 as a valuable therapeutic target in psoriasis.
Mesh Terms:
Biomarkers, CARD Signaling Adaptor Proteins, Caspases, Catalysis, Cytokines, Enzyme Activation, Gene Expression Regulation, Guanylate Cyclase, Humans, Keratinocytes, MAP Kinase Signaling System, Membrane Proteins, Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein, Mutation, NF-kappa B, Neoplasm Proteins, Protein Binding, Psoriasis, Signal Transduction
EMBO Rep.
Date: Dec. 01, 2015
Download Curated Data For This Publication
207017
Switch View:
  • Interactions 2